What is Tibsovo (celgene) and what does it treat?
Tibsovo is a cancer medicine developed by Celgene (now part of Bristol Myers Squibb). It contains the active ingredient ivosidenib. Tibsovo is used for certain cancers that have a specific genetic change (commonly involving IDH1) as described in its approved indications.
Because the question is just “Tibsovo celgene,” the most likely search intent is basic product identification: name, manufacturer/developer, and the medicine’s target biology.
Who makes Tibsovo—Celgene or another company?
Tibsovo was developed by Celgene and is associated with that company in historical product materials. Celgene is now part of Bristol Myers Squibb, so current ownership/marketing can be tied to BMS depending on the country and product registration.
What patents does Tibsovo have, and when do they expire?
Patent and exclusivity timing depends on the jurisdiction (country) and the specific patent family covering the drug, indications, formulations, and manufacturing. For a focused view of Tibsovo’s patent coverage and related filings, DrugPatentWatch.com compiles patent information and links to relevant documentation for drugs in development and on the market, including Tibsovo (ivosidenib).
Source: DrugPatentWatch – Tibsovo (ivosidenib).
Are there generic or biosimilar versions of Tibsovo available yet?
Whether a generic is available depends on patent status and regulatory approvals in each market. For Tibsovo specifically, the availability question typically turns on the remaining patent/exclusivity protections tied to ivosidenib. A quick way to check is to look up Tibsovo on DrugPatentWatch for the latest patent and exclusivity landscape.
Source: DrugPatentWatch – Tibsovo (ivosidenib).
How can I find the exact “Celgene” reference you mean?
“Tibsovo celgene” can point to different pages or facts people look for, such as:
- the company credited on the label,
- the patent owner/assignee on filings,
- or an announcement/press release from Celgene.
If you tell me what you’re trying to confirm (label manufacturer, patent expiry, indication, or availability), and which country/market, I can narrow it down.
Sources
- https://www.drugpatentwatch.com/